221 related articles for article (PubMed ID: 28809961)
21. Functional Genomics Reveals Linkers Critical for Influenza Virus Polymerase.
Wang L; Wu A; Wang YE; Quanquin N; Li C; Wang J; Chen HW; Liu S; Liu P; Zhang H; Qin FX; Jiang T; Cheng G
J Virol; 2015 Dec; 90(6):2938-47. PubMed ID: 26719244
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of PA endonuclease activity of influenza virus RNA polymerase by Kampo medicines.
Shirayama R; Shoji M; Sriwilaijaroen N; Hiramatsu H; Suzuki Y; Kuzuhara T
Drug Discov Ther; 2016; 10(2):109-13. PubMed ID: 26902927
[TBL] [Abstract][Full Text] [Related]
23. Identification of a novel compound with antiviral activity against influenza A virus depending on PA subunit of viral RNA polymerase.
Yamada K; Koyama H; Hagiwara K; Ueda A; Sasaki Y; Kanesashi SN; Ueno R; Nakamura HK; Kuwata K; Shimizu K; Suzuki M; Aida Y
Microbes Infect; 2012 Aug; 14(9):740-7. PubMed ID: 22441116
[TBL] [Abstract][Full Text] [Related]
24. Mapping the domain structure of the influenza A virus polymerase acidic protein (PA) and its interaction with the basic protein 1 (PB1) subunit.
Guu TS; Dong L; Wittung-Stafshede P; Tao YJ
Virology; 2008 Sep; 379(1):135-42. PubMed ID: 18657841
[TBL] [Abstract][Full Text] [Related]
25. Endonuclease substrate selectivity characterized with full-length PA of influenza A virus polymerase.
Noble E; Cox A; Deval J; Kim B
Virology; 2012 Nov; 433(1):27-34. PubMed ID: 22841552
[TBL] [Abstract][Full Text] [Related]
26. Identification and characterization of influenza variants resistant to a viral endonuclease inhibitor.
Song MS; Kumar G; Shadrick WR; Zhou W; Jeevan T; Li Z; Slavish PJ; Fabrizio TP; Yoon SW; Webb TR; Webby RJ; White SW
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3669-74. PubMed ID: 26976575
[TBL] [Abstract][Full Text] [Related]
27. [Structural and Biochemical Analyses on the RNA-dependent RNA Polymerase of Influenza Virus for Development of Novel Anti-influenza Agents].
Hatakeyama D
Yakugaku Zasshi; 2017; 137(2):205-214. PubMed ID: 28154333
[TBL] [Abstract][Full Text] [Related]
28. Influenza A virus polymerase: an attractive target for next-generation anti-influenza therapeutics.
Zhou Z; Liu T; Zhang J; Zhan P; Liu X
Drug Discov Today; 2018 Mar; 23(3):503-518. PubMed ID: 29339107
[TBL] [Abstract][Full Text] [Related]
29. Biophysical characterization of sites of host adaptive mutation in the influenza A virus RNA polymerase PB2 RNA-binding domain.
Lim K; Kim M; Lee MK; Ko J; Hong S; Choi BS
Int J Biochem Cell Biol; 2014 Aug; 53():237-45. PubMed ID: 24875650
[TBL] [Abstract][Full Text] [Related]
30. The Surface-Exposed PA
Nilsson-Payant BE; Sharps J; Hengrung N; Fodor E
J Virol; 2018 Aug; 92(16):. PubMed ID: 29875249
[TBL] [Abstract][Full Text] [Related]
31. Hsp90 inhibitors reduce influenza virus replication in cell culture.
Chase G; Deng T; Fodor E; Leung BW; Mayer D; Schwemmle M; Brownlee G
Virology; 2008 Aug; 377(2):431-9. PubMed ID: 18570972
[TBL] [Abstract][Full Text] [Related]
32. Functional domains of the influenza A virus PB2 protein: identification of NP- and PB1-binding sites.
Poole E; Elton D; Medcalf L; Digard P
Virology; 2004 Mar; 321(1):120-33. PubMed ID: 15033571
[TBL] [Abstract][Full Text] [Related]
33. Molecular mapping of influenza virus RNA polymerase by site-specific antibodies.
Masunaga K; Mizumoto K; Kato H; Ishihama A; Toyoda T
Virology; 1999 Mar; 256(1):130-41. PubMed ID: 10087233
[TBL] [Abstract][Full Text] [Related]
34. In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit.
Noshi T; Kitano M; Taniguchi K; Yamamoto A; Omoto S; Baba K; Hashimoto T; Ishida K; Kushima Y; Hattori K; Kawai M; Yoshida R; Kobayashi M; Yoshinaga T; Sato A; Okamatsu M; Sakoda Y; Kida H; Shishido T; Naito A
Antiviral Res; 2018 Dec; 160():109-117. PubMed ID: 30316915
[TBL] [Abstract][Full Text] [Related]
35. Identification of influenza polymerase inhibitors targeting C-terminal domain of PA through surface plasmon resonance screening.
Lo CY; Li OT; Tang WP; Hu C; Wang GX; Ngo JC; Wan DC; Poon LL; Shaw PC
Sci Rep; 2018 Feb; 8(1):2280. PubMed ID: 29396435
[TBL] [Abstract][Full Text] [Related]
36. A novel small-molecule inhibitor of influenza A virus acts by suppressing PA endonuclease activity of the viral polymerase.
Yuan S; Chu H; Singh K; Zhao H; Zhang K; Kao RY; Chow BK; Zhou J; Zheng BJ
Sci Rep; 2016 Mar; 6():22880. PubMed ID: 26956222
[TBL] [Abstract][Full Text] [Related]
37. The active sites of the influenza cap-dependent endonuclease are on different polymerase subunits.
Li ML; Rao P; Krug RM
EMBO J; 2001 Apr; 20(8):2078-86. PubMed ID: 11296240
[TBL] [Abstract][Full Text] [Related]
38. Involvement of Hsp90 in assembly and nuclear import of influenza virus RNA polymerase subunits.
Naito T; Momose F; Kawaguchi A; Nagata K
J Virol; 2007 Feb; 81(3):1339-49. PubMed ID: 17121807
[TBL] [Abstract][Full Text] [Related]
39. A peptide derived from the C-terminus of PB1 inhibits influenza virus replication by interfering with viral polymerase assembly.
Li C; Ba Q; Wu A; Zhang H; Deng T; Jiang T
FEBS J; 2013 Feb; 280(4):1139-49. PubMed ID: 23279951
[TBL] [Abstract][Full Text] [Related]
40. Identification of novel inhibitor against endonuclease subunit of Influenza pH1N1 polymerase: A combined molecular docking, molecular dynamics, MMPBSA, QMMM and ADME studies to combat influenza A viruses.
Mohseni SS; Nasri F; Davari K; Mirzaie S; Moradzadegan A; Abdi F; Farzaneh F
Comput Biol Chem; 2018 Dec; 77():279-290. PubMed ID: 30396155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
